Mulberry leaf extract and blood sugar after meals in children with obesity
Tests a mulberry leaf supplement on blood sugar in children and teenagers with obesity.
Plain-language title generated from the registry record
Registry title: Effects of Mulberry Leaf Extract Formulation on Postprandial Glycemic Levels in Obese Children and Adolescents
Key facts
- Where
- Bari, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 16 years old?
Source: NCT07494253, who can take part
Where in Italy
- Ospedale Pediatrico Giovanni XXIIIBari, ItalyNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Bari Aldo Moro
- Trial code
- NCT07494253
- Record updated
- 22 June 2026
- Original description
The study entitled "Effects of mulberry leaf extract formulationon Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents.Read full original descriptionShow less
Effects of Mulberry Leaf Extract Formulation on Postprandial Glycemic Levels in Obese Children and Adolescents: A Pilot Study (PEDRED)
The study entitled "Effects of mulberry leaf extract formulationon Postprandial Glycemic Peak in Obese Children and Adolescents: A Pilot Study" aims to evaluate the improvement in glycemic and insulinemic levels produced by a food supplement extracted from white mulberry (Morus alba), after 12 weeks of treatment in a cohort of obese children and adolescents.
Clinical and anthropometric data (age, sex, weight, height, BMI, pubertal stage) will be collected, along with data from blood chemistry tests performed during routine follow-up visits, in accordance with Good Clinical Practice guidelines.
Inclusion: Body mass index (BMI) >95° percentile for age and sex, according to WHO growth standards; absence of chronic deseases.
Exclusion: chronic use of steroid drugs; diagnosis of type 1 diabetes; known allergies or hypersensitvity to any component of the stusy product (Reducose); use of medications known to affect glucose metabolism.